Abstract
In healthy volunteers, the simultaneous administration of nifedipine and cefixime has been shown to increase the oral absorption of the antibiotic. To investigate the pharmacological basis of this interaction, we used an in situ intestinal perfusion technique in the rat. pH 5.5 yielded optimum cefixime absorption, which was greater in segments from the duodenojejunum than in those from the jejunoileum. Cefixime absorption was similar when perfused at 0.5 and 1.0 mg/ml, suggesting transport saturation at the lower concentration. Cefixime arterial and portal blood concentrations after an intestinal perfusion of 0.5 mg/ml cefixime were significantly increased by a previous 15-min intestinal perfusion of 0.05 mg/ml nifedipine. Nifedipine did not significantly alter intestinal blood flow. At the end of the cefixime perfusion, intestinal blood flow was higher in the nifedipine group than in the control group (0.44 ± 0.12vs. 0.26 ± 0.09 ml · min−1 · g of intestine wt−1, respectively), although the difference did not reach statistical significance. The absorption kinetics of salicylic acid, which is strictly absorbed by passive diffusion, were unaffected by nifedipine. After 15 and 50 min of recirculation, residual salicylate levels fell from 85.1 ± 5.6% to 57.1 ± 2.8% with nifedipine compared with 87.4 ± 1.4% to 52.8 ± 1.6% without nifedipine. Thus, the improvement in cefixime absorption by nifedipine was not secondary to increased local blood flows or to induced passive diffusion mechanisms. Nifedipine did not affect intestinal motility. The action of nifedipine appears to indirect, involving a neural regulation, because any increase in cefixime absorption was prevented by tetrodotoxin and hexamethonium administration.
Footnotes
-
Send reprint requests to: Prof. R. Farinotti, G.H. Bichat–Cl. Bernard, Service de pharmacie Clinique et des Biomatériaux, 46 rue H. Huchard, 75018 Paris, France.
-
↵1 L. Harcouët, C. Carbon and R. Farinotti, unpublished observations.
- Abbreviations:
- HM
- hexamethonium
- PKC
- protein kinase C
- PYY
- peptide YY
- TTX
- tetrodotoxin
- Received March 7, 1996.
- Accepted December 31, 1996.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|